Chloromycetin: Potent Broad-Spectrum Antibiotic Therapy
| Product dosage: 500mg | |||
|---|---|---|---|
| Package (num) | Per pill | Price | Buy |
| 60 | $0.87 | $52.21 (0%) | 🛒 Add to cart |
| 90 | $0.79 | $78.31 $71.29 (9%) | 🛒 Add to cart |
| 120 | $0.76 | $104.42 $91.37 (13%) | 🛒 Add to cart |
| 270 | $0.69 | $234.94 $185.75 (21%) | 🛒 Add to cart |
| 360 | $0.67
Best per pill | $313.26 $242.98 (22%) | 🛒 Add to cart |
Similar products
Chloromycetin (chloramphenicol) is a time-tested, broad-spectrum bacteriostatic antibiotic with a well-documented efficacy profile against a wide range of serious bacterial infections. Its mechanism of action involves inhibition of bacterial protein synthesis by binding to the 50S ribosomal subunit, making it particularly effective against both gram-positive and gram-negative organisms, including certain anaerobic bacteria and rickettsiae. While its use is reserved for severe infections where less hazardous agents are ineffective or contraindicated, it remains a critical tool in specific clinical scenarios. Healthcare providers must exercise judicious prescribing practices due to its associated risk profile, particularly concerning hematologic toxicity.
Features
- Contains chloramphenicol as the active pharmaceutical ingredient
- Available in oral, topical, and parenteral formulations
- Exhibits bacteriostatic activity against a wide spectrum of pathogens
- Demonstrates excellent tissue penetration, including cerebrospinal fluid
- Stable at room temperature with appropriate storage conditions
- Multiple strength options available for precise dosing
Benefits
- Effective against multidrug-resistant bacterial strains where other antibiotics fail
- Rapid achievement of therapeutic concentrations in various body tissues and fluids
- Provides reliable coverage for difficult-to-treat infections including typhoid fever and bacterial meningitis
- Flexible administration routes allow for tailored treatment approaches
- Established clinical history with well-characterized efficacy and safety profile
- Cost-effective alternative for certain serious infections in resource-limited settings
Common use
Chloromycetin is primarily indicated for serious infections caused by susceptible organisms when less potentially dangerous agents are ineffective or contraindicated. Its use includes treatment of typhoid fever caused by Salmonella typhi, bacterial meningitis caused by Haemophilus influenzae, and rickettsial diseases such as Rocky Mountain spotted fever. It is also employed for serious infections involving Bacteroides fragilis and other anaerobic bacteria, as well as for certain gram-negative bacterial infections resistant to other antimicrobial agents. Topical formulations are used for ocular infections including bacterial conjunctivitis, and otic preparations address external ear infections caused by susceptible organisms.
Dosage and direction
Dosage must be individualized based on the infection severity, pathogen susceptibility, patient age, renal and hepatic function, and serum concentrations where monitoring is available. For adults with serious infections, the usual oral or intravenous dose ranges from 50-100 mg/kg/day divided into 4 equal doses, not to exceed 4 grams daily. For typhoid fever, 50 mg/kg/day in divided doses for 14-21 days is typical. Pediatric dosing requires careful calculation based on body weight, with monitoring of serum levels recommended to maintain concentrations between 10-20 mcg/mL. Topical ophthalmic preparations are typically administered as one or two drops in the affected eye(s) every 3-6 hours, depending on severity. Complete the full course of therapy even if symptoms improve to prevent development of resistance.
Precautions
Chloromycetin requires careful hematologic monitoring due to the risk of bone marrow suppression, including periodic blood counts during therapy. Use with caution in patients with hepatic or renal impairment, as reduced clearance may lead to accumulation and increased toxicity risk. Avoid concurrent use with other medications known to cause bone marrow suppression. Monitor for superinfection or fungal overgrowth during prolonged therapy. Use during pregnancy only if clearly needed and potential benefits justify potential fetal risk, as chloramphenicol crosses the placental barrier. Exercise particular caution in premature infants and newborns due to the risk of “gray baby syndrome” resulting from immature metabolic pathways.
Contraindications
Chloromycetin is contraindicated in patients with known hypersensitivity to chloramphenicol or any component of the formulation. It should not be used for the treatment of trivial infections, as prophylaxis, or for bacterial infections treatable with other appropriate antimicrobial agents. Contraindicated in patients with a history of chloramphenicol-induced blood dyscrasias. Avoid use in infants under 2 weeks of age unless no alternative therapy exists and serum levels can be monitored. Not recommended for patients with pre-existing bone marrow depression or hematologic disorders.
Possible side effect
The most serious adverse effect is bone marrow suppression, which may manifest as anemia, leukopenia, thrombocytopenia, or potentially fatal aplastic anemia (which may occur weeks or months after therapy). Gastrointestinal disturbances including nausea, vomiting, and diarrhea are common. Neurologic effects may include optic neuritis, peripheral neuropathy, or headache. Hypersensitivity reactions ranging from skin rashes to anaphylaxis may occur. Gray baby syndrome in neonates characterized by abdominal distension, cyanosis, vasomotor collapse, and death. Superinfections with nonsusceptible organisms may develop. Jarisch-Herxheimer reaction has been reported during treatment of spirochetal infections.
Drug interaction
Chloromycetin may inhibit the metabolism of drugs metabolized by hepatic microsomal enzymes, potentially increasing serum levels of anticoagulants, phenytoin, tolbutamide, and chlorpropamide. Concurrent use with other bone marrow suppressants (chemotherapeutic agents, radiation therapy) may increase hematologic toxicity. May antagonize the bactericidal effects of penicillins and aminoglycosides in certain infections. Barbiturates may reduce chloramphenicol concentrations by inducing hepatic enzymes. Concurrent administration with iron preparations, vitamin B12, or folic acid may delay response to chloramphenicol.
Missed dose
If a dose is missed, administer it as soon as remembered unless it is almost time for the next scheduled dose. In that case, skip the missed dose and resume the regular dosing schedule. Do not double the dose to make up for a missed administration. Maintenance of consistent serum levels is important for therapeutic efficacy, particularly in serious infections. If multiple doses are missed or the treatment schedule is significantly disrupted, consult the prescribing healthcare provider for guidance on resumption of therapy.
Overdose
Acute overdose may cause nausea, vomiting, and gastrointestinal distress. Massive overdose (particularly in infants) may lead to cardiovascular collapse (gray syndrome) characterized by abdominal distension, cyanosis, vasomotor collapse, irregular respiration, and death. Treatment is supportive and symptomatic, with immediate gastric lavage if ingestion was recent. Hemodialysis is ineffective for removal due to high protein binding, but exchange transfusion may be considered in severe pediatric cases. Monitor hematologic parameters for several weeks after overdose due to risk of delayed bone marrow suppression.
Storage
Store at controlled room temperature (20-25°C or 68-77°F), protecting from light and moisture. Keep containers tightly closed. Do not freeze liquid formulations. Oral suspensions should be shaken well before administration. Parenteral solutions should be inspected for particulate matter and discoloration before use. Discard any unused portion of reconstituted solutions according to manufacturer recommendations. Keep all medications out of reach of children and pets. Do not use beyond the expiration date printed on the packaging.
Disclaimer
This information is provided for educational purposes only and does not constitute medical advice. Chloromycetin is a potent antibiotic with serious potential adverse effects and should be used only under the supervision of a qualified healthcare professional. The prescribing physician must weigh potential benefits against risks for each individual patient. Patients should not self-medicate with this drug and must follow their healthcare provider’s instructions precisely. Always consult with a healthcare professional for diagnosis and treatment of medical conditions.
Reviews
“Chloromycetin remains an essential antibiotic in our infectious disease arsenal for multidrug-resistant typhoid cases. While we respect its toxicity profile, when used appropriately with monitoring, it has proven lifesaving in numerous challenging cases.” - Infectious Disease Specialist, 15 years experience
“In ophthalmology, chloramphenicol drops continue to be effective for bacterial conjunctivitis when newer agents fail. The broad spectrum coverage is particularly valuable in cases where culture results are pending.” - Ophthalmologist, 8 years experience
“Having treated complicated anaerobic infections for decades, I still find chloramphenicol invaluable for certain Bacteroides infections that demonstrate resistance to metronidazole. The key is careful patient selection and monitoring.” - General Surgeon, 25 years experience
“While we use chloramphenicol sparingly in pediatric practice due to safety concerns, it remains important for specific serious infections like ampicillin-resistant H. influenzae meningitis. Dose calculation and monitoring are critical.” - Pediatric Infectious Disease Specialist, 12 years experience